Invesco
CRVS icon

Invesco’s Corvus Pharmaceuticals CRVS Stock Holding History

Invesco’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$559K Sell
38,212
-5,371
-12% -$85.7K ﹤0.01% 3119
2025
Q4 		$336K Buy
43,583
+4,910
+13% +$38.7K ﹤0.01% 3343
2025
Q3 		$285K Sell
38,673
-1,934
-5% -$9.9K ﹤0.01% 3439
2025
Q2 		$162K Buy
+40,607
New +$148K ﹤0.01% 3569
2023
Q4 		– Sell
-15,617
Closed -$22.8K – 3841
2023
Q3 		$22.8K Buy
15,617
+4,672
+43% +$9.88K ﹤0.01% 3853
2023
Q2 		$25.1K Buy
+10,945
New +$22.7K ﹤0.01% 3853

Other funds holding CRVS

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco's CRVS Position: Q1 2026 in Review

Invesco reduced its Corvus Pharmaceuticals (CRVS) stake by 12% in Q1 2026, selling an estimated $85.7K and leaving 38,212 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #3119.

Invesco first reported a position in CRVS in Q2 2023 and has held it in 6 quarters since. 164 funds tracked by Wall St. Rank hold CRVS as of Q1 2026.

  • Invesco held 38,212 shares of Corvus Pharmaceuticals worth $559K as of Q1 2026.
  • Invesco sold 5,371 Corvus Pharmaceuticals shares in Q1 2026, an estimated $85.7K.
  • Corvus Pharmaceuticals made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3119 holding.
  • Invesco first reported a position in Corvus Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
  • 164 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.